Piyasa Haberleri

0 0 0

Kaynak: Reuters Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

SpaceX's mobile ambitions jolt US telecom market, analysts debate threat

SpaceX's ambition to build a full-fledged mobile service rattled investors in the U.S. wireless sector on Tuesday, as the company outlined plans that ‌could eventually pit Starlink against industry leaders Verizon, AT&T and T-Mobile.

İlgili Semboller 1

P P-SPAC P-SPAC

Kaynak: Reuters

0 0 0

Kaynak: GlobeNewsWire Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering

SAN CARLOS, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced the pricing of its upsized initial public offering of 17,000,000 shares of its common stock at an initial public offering price of $17.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $289.0 million. All shares of common stock to be sold in the offering will be sold by Attovia. In addition, Attovia has granted the underwriters a 30-day option to purchase up to an additional 2,550,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. Attovia's common stock is expected to begin trading on the Nasdaq Global Market on August 5, 2026, under the symbol “ATTO.” The offering is expected to close on August 6, 2026, subject to the satisfaction of customary closing conditions.

İlgili Semboller 1

A ATTO ATTO

Kaynak: GlobeNewsWire

0 0 0

Kaynak: Seeking Alpha Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

BlackLine, Inc. (BL) Q2 2026 Earnings Call Transcript

İlgili Semboller 1

B BL BL

Kaynak: Seeking Alpha

0 0 0

Kaynak: Seeking Alpha Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Lumen Technologies, Inc. (LUMN) Q2 2026 Earnings Call Transcript

İlgili Semboller 1

L LUMN LUMN

Kaynak: Seeking Alpha

0 0 0

Kaynak: Seeking Alpha Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

TPG Inc. (TPG) Q2 2026 Earnings Call Transcript

İlgili Semboller 1

T TPG TPG

Kaynak: Seeking Alpha

0 0 0

Kaynak: Seeking Alpha Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Cavco Industries: Manufactured Housing's Edge Endures

Cavco Industries, Inc. reported a stable fiscal Q1 sales performance in a weak housing market. CVCO's margin performance did reflect housing market conditions, as the company's retail pricing power is limited. The newly effective housing bill helps CVCO significantly, especially as the bill includes separate provisions for manufactured housing.

İlgili Semboller 1

C CVCO CVCO

Kaynak: Seeking Alpha

0 0 0

Kaynak: PRNewsWire Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

DNOW Investors Have Opportunity to Lead DNOW Inc. Securities Lawsuit Filed by The Rosen Law Firm

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of all persons or entities who held DNOW Inc. (NYSE: DNOW) common stock as of the August 5, 2025 record date and were thus entitled to vote at the September 9, 2025 special meeting. A class action lawsuit has already been filed.

İlgili Semboller 1

D DNOW DNOW

Kaynak: PRNewsWire

0 0 0

Kaynak: MarketBeat Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

The Hackett Group Q2 Earnings Call Highlights

The Hackett Group NASDAQ: HCKT reported second-quarter 2026 revenue before reimbursements of $68.3 million and adjusted diluted earnings per share of $0.34, as the consulting firm continued its transition toward an AI-enabled, platform-led sales and delivery model.

İlgili Semboller 1

H HCKT HCKT

Kaynak: MarketBeat

0 0 0

Kaynak: MarketBeat Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Gilead Sciences Q2 Earnings Call Highlights

Gilead Sciences NASDAQ: GILD reported second-quarter 2026 base business sales growth of 10% year over year to $7.6 billion, supported by HIV treatments and prevention products, Trodelvy in oncology and Livdelzi in liver disease. The company raised its full-year base business sales outlook and increased its expected HIV growth rate, while reporting a quarterly non-GAAP loss driven by acquisition-related research and development charges.

İlgili Semboller 1

G GILD GILD

Kaynak: MarketBeat

0 0 0

Kaynak: MarketBeat Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Freshworks Q2 Earnings Call Highlights

Freshworks NASDAQ: FRSH reported second-quarter 2026 revenue of $237.4 million, up 16% year over year on a reported basis and 15% in constant currency, as the company highlighted continued growth in its employee experience, or EX, business and an earlier-than-expected move to GAAP profitability.

İlgili Semboller 1

F FRSH FRSH

Kaynak: MarketBeat

0 0 0

Kaynak: MarketBeat Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Flywire Q2 Earnings Call Highlights

Flywire NASDAQ: FLYW reported second-quarter results that exceeded its expectations, led by travel performance, hospitality payment processing and stronger-than-anticipated contributions from healthcare and B2B payment-processing ramps. The company also raised its full-year revenue and adjusted EBITDA outlook, while maintaining a cautious posture toward international student visa trends in major education markets.

İlgili Semboller 1

F FLYW FLYW

Kaynak: MarketBeat

0 0 0